SiBionics has announced that it has received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system.
The company designed its CGM system to provide healthcare providers and patients with the data necessary for maintaining glucose control. It offers 14 days of calibration-free continuous glucose monitoring and can transmit data to monitoring devices or mobile applications.
GS1 not only supports data sharing with friends and family but integrates with the ProView remote access platform, which allows healthcare providers to remotely monitor and provide timely medical interventions.
To find out more, CLICK HERE.